Organization
Perfuse Therapeutics
2 clinical trials
Clinical trial
A Phase 1/2a Study to Evaluate Safety, Tolerability, and Pharmacodynamic Effect After Single Administration of PER-001 Intravitreal Implant in Participants With Open-Angle GlaucomaStatus: Recruiting, Estimated PCD: 2024-08-30
Clinical trial
A Phase 2a Study to Evaluate Safety and Tolerability After Single Administration of PER-001 Intravitreal Implant in Participants With Diabetic RetinopathyStatus: Recruiting, Estimated PCD: 2024-11-30